Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroplasticity of Pain Pathways and Corneal Afferent Regeneration Following Corneal Crosslinking (CXL) in Keratoconus

NCT04439552 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT04439552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04439552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroplasticity of Pain Pathways and Corneal Afferent Regeneration Following Corneal Crosslinking (CXL) in Keratoconus
Lead sponsor
Boston Children's Hospital
Phase
Observational
Overall status
Recruiting
Start date
October 4, 2021
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cornea, cornea injury, keratoconus, pain, acute, pain, chronic, pain, postoperative, surgical injury, surgical wound